Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Modified-Release Drug Delivery Systems: Site-Targeted

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...

Transdermal Drug Delivery Systems

Transdermal Drug Delivery Systems

Transdermal drug delivery systems (TDDS) enable the controlled release of drugs across the skin into systemic circulation. They are particularly advantageous for drugs with short half-lives or narrow therapeutic indices, as they maintain consistent plasma concentrations and reduce the risk of subtherapeutic or toxic levels.TDDS are categorized into monolithic, reservoir, and mixed systems. Monolithic systems embed the drug in a polymer matrix, where diffusion governs release. Reservoir systems...

Modified-Release Drug Delivery Systems: Rate-Programmed II

Modified-Release Drug Delivery Systems: Rate-Programmed II

Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...

Intrauterine Drug Delivery Systems

Intrauterine Drug Delivery Systems

Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...

Modified-Release Drug Delivery Systems: Classification

Modified-Release Drug Delivery Systems: Classification

Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Biodegradable calcium sulfide-based nanomodulators for H<sub>2</sub>S-boosted Ca<sup>2+</sup>-involved synergistic cascade cancer therapy.

Acta pharmaceutica Sinica. B·2022

Same author

Boosting Nitrogen Activation <i>via</i> Ag Nanoneedle Arrays for Efficient Ammonia Synthesis.

ACS nano·2022

Same author

Engineered drug-loaded cellular membrane nanovesicles for efficient treatment of postsurgical cancer recurrence and metastasis.

Science advances·2022

Same author

Updates of ocular involvement in granulomatosis with polyangiitis.

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie·2022

Same author

DOK7 Promotes NMJ Regeneration After Nerve Injury.

Molecular neurobiology·2022

Same author

Predictive nomogram for deep brain stimulation-related infections.

Neurosurgical focus·2022

Search research articles

Related Experiment Video

Updated: May 15, 2026

Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles

Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles

Published on: August 2, 2016

Paclitaxel drug delivery systems.

Zhiping Zhang¹, Lin Mei, Si-Shen Feng

¹Huazhong University of Science & Technology, Tongji School of Pharmacy and National Engineering Research Center for Nanomedicine, Wuhan 430030, China.

Expert Opinion on Drug Delivery

|January 8, 2013

Summary

Paclitaxel (PTX) drug delivery faces challenges due to poor water solubility. Nanotechnology offers solutions for enhanced solubility, targeted delivery, and reduced side effects of this crucial chemotherapy agent.

More Related Videos

Facile Preparation of Internally Self-assembled Lipid Particles Stabilized by Carbon Nanotubes

Facile Preparation of Internally Self-assembled Lipid Particles Stabilized by Carbon Nanotubes

Published on: February 19, 2016

Preparation and Characterization of Individual and Multi-drug Loaded Physically Entrapped Polymeric Micelles

Preparation and Characterization of Individual and Multi-drug Loaded Physically Entrapped Polymeric Micelles

Published on: August 28, 2015

Related Experiment Videos

Last Updated: May 15, 2026

Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles

Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles

Published on: August 2, 2016

Facile Preparation of Internally Self-assembled Lipid Particles Stabilized by Carbon Nanotubes

Facile Preparation of Internally Self-assembled Lipid Particles Stabilized by Carbon Nanotubes

Published on: February 19, 2016

Preparation and Characterization of Individual and Multi-drug Loaded Physically Entrapped Polymeric Micelles

Preparation and Characterization of Individual and Multi-drug Loaded Physically Entrapped Polymeric Micelles

Published on: August 28, 2015

Area of Science:

Pharmaceutical Nanotechnology
Drug Delivery Systems
Cancer Therapeutics

Background:

Paclitaxel (PTX) is a potent broad-spectrum chemotherapy agent.
Poor water solubility limits PTX clinical application and necessitates adjuvants with side effects.
Current PTX formulations exhibit suboptimal pharmacokinetics and biodistribution.

Purpose of the Study:

To review recent advancements in paclitaxel delivery systems.
To highlight nanotechnology-based solutions for PTX formulation challenges.
To explore methods for enhancing PTX solubility, permeability, stability, and targeted delivery.

Main Methods:

Review of various PTX delivery systems including prodrugs, micelles, liposomes, and nanoparticles.
Discussion of solid lipid nanoparticles, biodegradable polymer nanoparticles, dendrimers, and nanohydrogels.
Inclusion of paclitaxel-eluting stents as a delivery modality.

Main Results:

Nanotechnology offers solutions for PTX formulation and delivery challenges.
Nanocarriers demonstrate high drug encapsulation efficiency and cellular uptake.
Surface modification and appropriate sizing enable evasion of macrophage elimination.
Ligand conjugation facilitates targeted drug delivery.

Conclusions:

Pharmaceutical nanotechnology provides effective strategies to overcome PTX limitations.
Nanocarriers can significantly improve PTX therapeutic efficacy and reduce side effects.
Advancements in nanodelivery systems are transforming drug formulation and administration.